Pregled bibliografske jedinice broj: 458787
HFE mutations and transferrin C1/C2 polymorphism among Croatian patients with schizophrenia and schizoaffective disorder
HFE mutations and transferrin C1/C2 polymorphism among Croatian patients with schizophrenia and schizoaffective disorder // Molecular biology reports, 39 (2011), 3; 2253-2258 doi:10.1007/s11033-011-0974-0 (međunarodna recenzija, članak, znanstveni)
CROSBI ID: 458787 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
HFE mutations and transferrin C1/C2 polymorphism among Croatian patients with schizophrenia and schizoaffective disorder
Autori
Buretić-Tomljanović, Alena ; Vraneković, Jadranka ; Rubeša, Gordana ; Jonovska, Suzana ; Tomljanović, Draško ; Šendula-Jengić, Vesna ; Kapović, Miljenko ; Ristić, Smiljana
Izvornik
Molecular biology reports (0301-4851) 39
(2011), 3;
2253-2258
Vrsta, podvrsta i kategorija rada
Radovi u časopisima, članak, znanstveni
Ključne riječi
schizophrenia; schizoaffective disorder; hemochromatosis gene mutations; transferrin gene variant; age at disease onset
(schizophrenia; schizoaffective disorder; hemochromatosis gene mutations; transferrin gene variant)
Sažetak
The aim of this study was to investigate the possible influence of hemochromatosis gene mutations (HFE-C282Y and H63D) and transferrin gene C2 variant (TF-C2) on susceptibility to schizophrenia and schizoaffective disorder and/or age at first hospital admission. Genotyping was performed in 176 Croatian patients and 171 non-psychiatric Croatian controls using PCR-RFLP analyses. Regarding the H63D mutation, allele and genotype frequencies reached boundary statistical significance. Other allele and genotype distributions were not significantly different between two groups. We also analyzed age at first hospital admission as a continuous variable using the non-parametric Mann-Whitney U-test and Kruskal-Wallis test, and multiple regression analysis. The results of these tests were negative. We concluded that investigated HFE mutations and TF-C2 variant are not high-risk genetic variants for schizophrenia/schizoaffective disorder in our population. Also, our data do not support their impact on age at onset of the first psychotic symptoms.
Izvorni jezik
Engleski
Znanstvena područja
Temeljne medicinske znanosti
POVEZANOST RADA
Projekti:
062-0982522-0369 - Genetika metabolizma fosfolipida u shizofreniji (Buretić-Tomljanović, Alena, MZOS ) ( CroRIS)
Ustanove:
Medicinski fakultet, Rijeka,
Znanstveno studijski centar
Profili:
Vesna Šendula-Jengić
(autor)
Smiljana Ristić
(autor)
Suzana Jonovska
(autor)
Gordana Rubeša
(autor)
Alena Buretić-Tomljanović
(autor)
Miljenko Kapović
(autor)
Jadranka Vraneković
(autor)
Citiraj ovu publikaciju:
Časopis indeksira:
- Current Contents Connect (CCC)
- Web of Science Core Collection (WoSCC)
- Science Citation Index Expanded (SCI-EXP)
- SCI-EXP, SSCI i/ili A&HCI
- Scopus
- MEDLINE
Uključenost u ostale bibliografske baze podataka::
- AGRICOLA
- ASFA: Aquatic Science and Fisheries Abstracts
- BIOSIS Previews (Biological Abstracts)
- CAB Abstracts
- CA Search (Chemical Abstracts)
- EMBASE (Excerpta Medica)
- MEDLINE
- PubMed
- Scopus
- Google Scholar
- EBSCO
- CSA
- CAB International
- Academic OneFile
- Biochemistry and Biophysics Citation Index
- Biotechnology Citation Index
- Current Abstracts